MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):56-57. doi: 10.15585/mmwr.mm7002e3.
In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward.
2020 年 7 月,佛罗里达州卫生部门接到报告,在一家急症医院(医院 A)的一个专门收治 2019 冠状病毒病(COVID-19)患者的 COVID-19 病房中,有 4 名 COVID-19 患者出现了 3 例耳念珠菌血流感染和 1 例尿路感染。耳念珠菌是一种具有多重耐药性的酵母,可引起侵袭性感染。它能够无症状定植于患者体内,并在表面持续存在,这导致了先前在医疗机构中发生的多起耳念珠菌暴发(1-7)。自 2017 年佛罗里达州首次发现耳念珠菌病例以来,已采取了包括接触者追踪和新病例检测筛查在内的积极措施来限制其传播。在 COVID-19 大流行之前,医院 A 对耳念珠菌进行了入院筛查,并将定植患者收治到一个单独的专门病房。